Current Problems in Cancer
Volume 33, Issue 4 , Pages 245-294, July 2009

Epidermal Growth Factor Receptor Inhibitors: Current Status and Future Directions

  • Helen X. Chen, MD

      Affiliations

    • Investigational Drug Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland
    • ,
  • Jessica N. Cleck, PhD

      Affiliations

    • Technical Resources International, Inc., Bethesda, Maryland
    • ,
  • Rochelle Coelho, PhD

      Affiliations

    • Technical Resources International, Inc., Bethesda, Maryland
    • ,
  • Janet E. Dancey, MD

      Affiliations

    • Ontario Institute for Cancer Research, Toronto, Ontario, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0147-0272(09)00047-6

doi:10.1016/j.currproblcancer.2009.10.002

Current Problems in Cancer
Volume 33, Issue 4 , Pages 245-294, July 2009

Article Tools

* Image Usage & Resolution